<DOC>
	<DOCNO>NCT00106496</DOCNO>
	<brief_summary>The purpose study determine impact topical corticosteroid safety effectiveness Protopic Ointment short-term treatment moderate severe Atopic Dermatitis compare safety effectiveness Protopic Ointment placebo long-term management Atopic Dermatitis</brief_summary>
	<brief_title>A Multi-Center Study Short Long-term Use Protopic Ointment Patients With Atopic Dermatitis</brief_title>
	<detailed_description>Study include interim short-term , open label period . Patients could also receive second course open label treatment dependent disease exacerbation .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patient must Atopic Dermatitis Patient must least 2 year age Patient pregnant breast feeding infant</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Immunomodulator , Topical</keyword>
	<keyword>Tacrolimus , Topical</keyword>
	<keyword>Dermatitis , Atopic</keyword>
	<keyword>Eczema , Atopic</keyword>
	<keyword>Atopic Dermatitis</keyword>
</DOC>